Gilead to Acquire Tubulis in $5 Billion Deal to Strengthen Cancer Drug Pipeline
Global biopharmaceutical company Gilead Sciences has announced a major acquisition of German biotech firm Tubulis in a deal…
Global biopharmaceutical company Gilead Sciences has announced a major acquisition of German biotech firm Tubulis in a deal…